Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Po‐Fu Yueh"'
Autor:
Po-Fu Yueh, Chih-Sheng Chiang, I-Jung Tsai, Yun-Long Tseng, He-Ru Chen, Keng-Li Lan, Fei-Ting Hsu
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-17 (2024)
Abstract Background Sunitinib is a multikinase inhibitor used to treat patients with advanced renal cell carcinoma (RCC). However, sunitinib toxicity makes it a double-edged sword. Potent immune modulation by sunitinib extends to nuclear interactions
Externí odkaz:
https://doaj.org/article/406b1db76099467581f66697017b3591
Autor:
Po-Fu Yueh, Yuan-Hao Lee, I-Tsang Chiang, Wei-Ting Chen, Keng-Li Lan, Cheng-Hsien Chen, Fei-Ting Hsu
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundAnti-depressants have been reported to own anti-tumor potential types of cancers; however, the role of imipramine in non-small cell lung cancer (NSCLC) has not been elucidated. Epidermal growth factor receptor (EGFR) was known to be one of
Externí odkaz:
https://doaj.org/article/77734ca65ef2422badb51b352c6b83a3
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 126, Iss , Pp 110054- (2020)
Fluoxetine, an antidepressant, has been indicated to elicit anti-cancer response in hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) in vitro. However, anticancer effect and mechanism of fluoxetine in HCC and NSCLC in vivo still
Externí odkaz:
https://doaj.org/article/4e19e3cc11584c009ead93b78b906c16
Publikováno v:
Life, Vol 11, Iss 12, p 1399 (2021)
Glioblastoma multiforme (GBM) is the most common form of malignant brain tumor, with poor prognosis; the efficacy of current standard therapy for GBM remains unsatisfactory. Magnolol, an herbal medicine from Magnolia officinalis, exhibited anticancer
Externí odkaz:
https://doaj.org/article/39d5464e6f704035babf7cce062b4535
Autor:
Fei‐Ting Hsu, Chang Liang Tsai, I‐Tsang Chiang, Keng‐Hsueh Lan, Po‐Fu Yueh, Wen‐Yi Liang, Chi‐Shuo Lin, Yee Chao, Keng‐Li Lan
Publikováno v:
Journal of Cellular and Molecular Medicine. 26:1955-1968
Nab-paclitaxel (Abraxane), which is a nanoparticle form of albumin-bound paclitaxel, is one of the standard chemotherapies for pancreatic ductal adenocarcinoma (PDAC). This study determined the effect of Abraxane in combination with a fusion protein,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f7897381a5be1157fe4e5cc1002e9d7
https://doi.org/10.1111/jcmm.17220
https://doi.org/10.1111/jcmm.17220
Autor:
CHI-HUAN LI, MING-CHOU KU, KUN-CHING LEE, PO-FU YUEH, FEI-TING HSU, RONG-FONG LIN, CHUNG-CHI YANG, WEI-CHUN WANG, JIANN-HWA CHEN, LI-CHO HSU, YUAN-HAO LEE
Publikováno v:
Anticancer research. 42(9)
Osteosarcoma is an aggressive primary malignant bone tumor that occurs in childhood. Although the diagnostic and treatment options have been improved, osteosarcoma confers poor prognosis. Magnolol, an active component of Magnoliae officinalis cortex,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a606dcc855fb1711273f4f8578355b70
https://pubmed.ncbi.nlm.nih.gov/36039427
https://pubmed.ncbi.nlm.nih.gov/36039427
Publikováno v:
Anticancer Research. 41:1357-1364
Background/aim Amentoflavone, an effective compound derived from medicinal plants, has been shown to boost therapeutic efficacy of chemotherapy in non-small cell lung cancer (NSCLC). However, anti-NSCLC effect of amentoflavone is ambiguous. The major
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73eb453d203e1e8154a3f6881e9f73fa
https://doi.org/10.21873/anticanres.14893
https://doi.org/10.21873/anticanres.14893
Publikováno v:
Cancer Research. 83:2003-2003
Renal cell carcinoma (RCC) is one of the deadliest malignant tumors worldwide. The RCC’s standard treatments are including surgery, radiation, and chemotherapy. SUTENT® (sunitinib) was approved by US Food and Drug Administration (FDA) in 2016 to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1e79d9cfcc2d2a356aedd8089fc0aaf
https://doi.org/10.1158/1538-7445.am2023-2003
https://doi.org/10.1158/1538-7445.am2023-2003
Publikováno v:
Cancer Research. 82:5067-5067
Pancreatic ductal adenocarcinoma (PDAC) is one of the hardest medical challenge in the world. Nab-paclitaxel is significantly more effective chemotherapy drugs than paclitaxel formulated as Cremophor EL. In this study, we reported the immune effect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8930270b2c89f61258003aff4a0edf59
https://doi.org/10.1158/1538-7445.am2022-5067
https://doi.org/10.1158/1538-7445.am2022-5067
Publikováno v:
Cancers
Volume 13
Issue 8
Cancers, Vol 13, Iss 1789, p 1789 (2021)
Volume 13
Issue 8
Cancers, Vol 13, Iss 1789, p 1789 (2021)
Simple Summary In this manuscript, we reported that a newly developed recombinant human IL15 fused with albumin binding domain (hIL15-ABD) showed superior biological half-life, pharmacokinetic and anti-tumor immunity than wild-type (WT) hIL15. Our hI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::063c0f41b0c1b347e1f87461f0414c69
https://pubmed.ncbi.nlm.nih.gov/33918641
https://pubmed.ncbi.nlm.nih.gov/33918641